Webinar | Small Portions, Big Satiety: The Rise of GLP-1 Inspired Foods Register Now

Mable (Neurolytic Healthcare)

Genomics based individualized care for people with neurological conditions.
2019
11-50
Oxford, Oxfordshire, United Kingdom
  • Bioanalytical Devices
  • Drug Delivery and Devices
  • Drug Discovery and Development
  • Medical Imaging and Visualization Technology
  • Personalized Medicine Technologies
  • Services (Patient care)
  • Wearables

Investment Funding

Last Funding Stage

Seed

Total Funding Amount

3.25M

Last Funding Amount

3.2M

Last Funding Date

27-07-2022

Startup Stage

Seed

Lead Investors

Y Combinator, Initialized Capital, Illumina, Creative Destruction Lab (CDL), Arkitekt Ventures

Revenue

$1M to $10M

People

Founders

Something missing or incorrect on this page? Help us enrich this information